当前位置: 首页 >> 检索结果
共有 62672 条符合本次的查询结果, 用时 7.7200321 秒

1. Elevated Resting Coronary Blood Flow Is Associated With Death, MI, and HF in All-Comer Patients With Chronic Coronary Syndrome.

作者: Shajan Shekarestan.;Fadi Jokhaji.;Christina Ekenbäck.;Mattias Törnerud.;Samantha Lörstad.;Petter Ljungman.;Nikolaos Östlund-Papadogeorgos.;Rikard Linder.;Bassem Samad.;Jonas Persson.
来源: Circ Cardiovasc Interv. 2026年e015867页
The prognostic implications of bolus thermodilution-derived resting coronary blood flow in all-comer patients with chronic coronary syndrome are not known. We investigated the association of thermodilution-derived indices characterizing coronary flow with outcomes.

2. Socioeconomic and Structural Barriers to Addressing Obesity in Communities: A Scientific Statement From the American Heart Association.

作者: Stephanie T Chung.;Josephine Harrington.;Namratha R Kandula.;Kiarri N Kershaw.;Morgana Mongraw-Chaffin.;Foster Osei Baah.;Angela F Pfammatter.;Michael V Stanton.;Fatima Cody Stanford.; .
来源: Circulation. 2026年
The obesity epidemic continues largely unabated, affecting more than one-third of the US population and disproportionately burdening individuals from socioeconomically disadvantaged populations. Numerous factors contribute to the high prevalence of obesity, including socioeconomic and structural barriers impeding primordial and primary prevention efforts. Despite broad recognition that social determinants of health are key drivers of obesity, the importance of socioeconomic and structural factors as contemporary barriers to individual-, community-, and population-level obesity prevention and intervention efforts remains underappreciated. This scientific statement highlights multilevel barriers to obesity prevention and management, with an emphasis on social determinants of health, societal culture, and shared biases that may interfere with the success of healthy weight management programs. The assessment includes a comprehensive review of policy and community-level strategies used to address the obesity epidemic and identifies key areas for future research.

3. Right Atrial Mass With Discordant Steroid Response: Cavernous Hemangioma With Cardiac Sarcoidosis.

作者: Tao Zeng.
来源: Circ Cardiovasc Imaging. 2026年e019203页

4. Response to Letter Regarding Article, "Prospective Observational Study on the Accuracy of Predictors of Permanent Pacemaker Secondary to High-Grade Atrioventricular Conduction Block After TAVI (CONDUCT-TAVI)".

作者: Karan Rao.;Ravinay Bhindi.
来源: Circ Cardiovasc Interv. 2026年e016343页

5. High Burden of Premature Ventricular Contractions Upregulates Transcriptional Markers of Inflammation and Promotes Adverse Cardiac Remodeling Linked to Cardiomyopathy.

作者: J M L Medina-Contreras.;Jaime Balderas-Villalobos.;Jose Gomez-Arroyo.;Janée Hayles.;Karoly Kaszala.;Alex Y Tan.;Montserrat Samsó.;Jose F Huizar.;Jose M Eltit.
来源: Circ Arrhythm Electrophysiol. 2026年e014195页
Premature ventricular contractions (PVCs) are the most prevalent ventricular arrhythmia in adults. High PVC burden can lead to left ventricular systolic dysfunction, eccentric hypertrophy, and an increased risk of heart failure and sudden cardiac death. Inadequate angiogenesis is a key determinant in the transition from adaptive to maladaptive cardiac hypertrophy, and fibrosis is a risk factor for arrhythmia and sudden cardiac death. We quantitatively assessed structural remodeling and transcriptional alterations in PVC-induced cardiomyopathy (PVC-CM).

6. Correction to: Transcatheter Closure of Patent Foramen Ovale with a Novel Biodegradable Device: A Prospective, Multicenter, Randomized Controlled Clinical Trial.

作者: Fengwen Zhang.;Jie Dong.;Peijian Wei.;Weiyi Fang.;Hao Hu.;Xiangqing Kong.;Ming Bai.;Jiahua Pan.;Zhiling Luo.;Ping Zhang.;Baiming Qu.;Jinpeng Hu.;Yaoxing Lu.;Chuangshi Wang.;Shouzheng Wang.;Xiangbin Pan.
来源: Circulation. 2026年153卷2期e13页

7. Correction to: Long-Term Outcomes of Early Surgery Versus Conventional Treatment for Asymptomatic Severe Mitral Regurgitation: A Propensity Analysis.

作者: Sung-Ji Park.;Mijin Kim.;Jihee Son.;Ha Hye Jo.;Ga Yun Kim.;Jihoon Kim.;Byung Joo Sun.;Eun-Kyung Kim.;Sahmin Lee.;Jae Suk Yoo.;Sung-Cheol Yun.;Sung-Ho Jung.;Jong-Min Song.;Duk-Hyun Kang.
来源: Circulation. 2026年153卷2期e12页

8. Correction to: Contemporary Burden of Cardiovascular Disease in Pregnancy: Insights From a Real-World Pregnancy Electronic Health Record Cohort.

作者: Emily S Lau.;Valentina D'Souza.;Yunong Zhao.;Christopher Reeder.;Rachel Goldberg.;Micayla Flores.;Katherine E Economy.;Mahnaz Maddah.;Shaan Khurshid.;Patrick T Ellinor.;Jennifer E Ho.
来源: Circulation. 2026年153卷2期e11页

9. Correction to: Myeloid Fatty Acid Metabolism Activates Neighboring Hematopoietic Stem Cells to Promote Heart Failure With Preserved Ejection Fraction.

作者: Mallory Filipp.;Zhi-Dong Ge.;Matthew DeBerge.;Connor Lantz.;Kristofor Glinton.;Peng Gao.;Sasha Smolgovsky.;Jingbo Dai.;You-Yang Zhao.;Laurent Yvan-Charvet.;Pilar Alcaide.;Samuel E Weinberg.;Gabriele G Schiattarella.;Joseph A Hill.;Matthew J Feinstein.;Sanjiv J Shah.;Edward B Thorp.
来源: Circulation. 2026年153卷2期e10页

10. When Less Is More: Is It Time for a New Gold Standard?

作者: Weiyi Tan.;Jamil Aboulhosn.
来源: Circulation. 2026年153卷2期82-85页

11. Profiling Immune-Independent Response to Immune Checkpoint Inhibitors on Stem Cell-Derived Cardiomyocytes, Organoids, and Mouse Models.

作者: Dilip Thomas.;Amit Manhas.;Yu Liu.;Ravichandra Venkateshappa.;Nadjet Belbachir.;Shane R Zhao.;Cody Juguilon.;Ian Y Chen.;Javid Moslehi.;Nazish Sayed.;Joseph C Wu.
来源: Circulation. 2026年153卷2期132-135页

12. Response by Sittichokkananon et al to Letter Regarding Article, "Genetic and Lifestyle Risks for Coronary Artery Disease and Long-Term Risk of Incident Dementia Subtypes".

作者: Arisa Sittichokkananon.;Victoria Garfield.;Scott T Chiesa.
来源: Circulation. 2026年153卷2期e6-e7页

13. Multivalve Involvement in Aortic Stenosis: Insights From a Narrative Review.

作者: Quentin Battistolo.;Marisa Avvedimento.;Patrice Guerin.;Pierre Yves Turgeon.;Mathieu Bernier.;Michael J Mack.;Patrick O'Gara.;Josep Rodés-Cabau.
来源: Circulation. 2026年153卷2期115-131页
Many patients with severe aortic stenosis present with concomitant multivalvular heart disease. The management of this condition remains challenging and requires a multidisciplinary approach that integrates clinical, hemodynamic, and multimodality imaging data to define the most effective and durable treatment strategy. Although randomized evidence to guide treatment decisions in this setting is limited, percutaneous interventions to address additional valvular lesions are being increasingly adopted. This review provides an overview of the pathophysiology of valvular diseases commonly associated with severe aortic stenosis, highlighting their prognostic implications after surgical or transcatheter treatment and their impact on risk stratification and therapeutic management.

14. François Abboud: Pioneer, Mentor, and Friend to Many.

作者: Maryjane Farr.;Joseph A Hill.
来源: Circulation. 2026年153卷2期69-70页

15. Letter by Yang and Lu Regarding Article, "Genetic and Lifestyle Risks for Coronary Artery Disease and Long-Term Risk of Incident Dementia Subtypes".

作者: Shiyu Yang.;Ying Lu.
来源: Circulation. 2026年153卷2期e4-e5页

16. Letter by Zhao Regarding Article, "Oral Semaglutide and Cardiovascular Outcomes in People With Type 2 Diabetes, According to SGLT2i Use: Prespecified Analyses of the SOUL Randomized Trial".

作者: Yun-Tao Zhao.
来源: Circulation. 2026年153卷2期e8-e9页

17. Identification of Heart Transplant Rejection Subtypes With Circulating MicroRNAs.

作者: Jason F Goldberg.;Pramita Bagchi.;Angela Mercado.;Keyur B Shah.;Samer S Najjar.;Inna Tchoukina.;Maria E Rodrigo.;Steven Hsu.;Moonkyoo Jang.;Hyesik Kong.;Charles C Marboe.;Gerald J Berry.;Hannah A Valantine.;Sean Agbor-Enoh.;Palak Shah.; .
来源: Circ Heart Fail. 2026年e013141页
Circulating microRNAs are promising biomarkers of acute cellular rejection (ACR) and antibody-mediated rejection (AMR) in heart transplantation. The study objective was to assess the characteristics and diagnostic performance of previously identified microRNAs and clinical rejection scores (CRS) in distinct blood samples obtained at the time of an endomyocardial biopsy (EMB).

18. Delay From First Symptoms in Patients Presenting With STEMI and Cardiogenic Shock: Insights From the DanGer Shock Trial.

作者: Lisette Okkels Jensen.;Rasmus Paulin Beske.;Hans Eiskjær.;Norman Mangner.;Amin Polzin.;P Christian Schulze.;Carsten Skurk.;Peter Nordbeck.;Peter Clemmensen.;Vasileios Panoulas.;Sebastian Zimmer.;Andreas Schäfer.;Nikos Werner.;Lene Holmvang.;Kristian Wachtell.;Thomas Engstøm.;Nanna Louise Junker Udesen.;Henrik Schmidt.;Anders Junker.;Christian Juhl Terkelsen.;Steffen Christensen.;Axel Linke.;Jacob Eifer Møller.;Christian Hassager.; .
来源: Circ Cardiovasc Interv. 2026年e015718页
Microaxial flow pump (mAFP) use in selected patients with ST-segment-elevation myocardial infarction complicated by cardiogenic shock improves survival. The present study aimed to assess the influence of delay from first symptoms to randomization on the benefit of an mAFP in patients with ST-segment-elevation myocardial infarction complicated by cardiogenic shock.

19. Evolution and Prognostic Value of Right Ventricular to Pulmonary Artery Coupling During Guideline-Directed Medical Therapy Up-Titration.

作者: Paul Le Dantec.;Théo Liets.;Julie Burdeau.;Quentin Laissac.;Camilia Hayoun.;Iliès Jaballah.;Samia Benchekroun.;Attoumane-Abdou Cheikh.;Corentin Chaumont.;Frédéric Anselme.;Eric Durand.;Hélène Eltchaninoff.;Charles Fauvel.
来源: Circ Heart Fail. 2026年e012980页
Up-titration of guideline-directed medical therapy (GDMT) is known to enhance left ventricular function in heart failure (HF) with reduced ejection fraction. However, data regarding its effect on right ventricular (RV) function remain sparse. We aimed to assess the impact of GDMT up-titration on the RV, especially RV to pulmonary artery coupling, and its prognostic value in these patients.

20. Impact of Advanced Cardiac Life Support Medications on Discharge Neurological Function for Survivors of Cardiac Arrest When Using ECPR.

作者: Maxwell Hockstein.;Nicholas J Johnson.;Joshua J Horns.;Scott T Youngquist.;Sung-Min Cho.;Joeseph Tonna.
来源: Circ Heart Fail. 2026年e013420页
While the immediate goal of cardiopulmonary resuscitation is to achieve return of spontaneous circulation, the patient-centered goal is to minimize neurological injury. Several medications used during cardiac arrest have been associated with poor neurological outcomes. For patients cannulated for veno-arterial extracorporeal membrane oxygenation during cardiac arrest, termed extracorporeal cardiopulmonary resuscitation, the patient-centered impact of these medications has not yet been described.
共有 62672 条符合本次的查询结果, 用时 7.7200321 秒